-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Alamar Biosciences, Raises Price Target to $35

Benzinga·08/11/2026 14:09:53
Listen to the news
JP Morgan analyst Casey Woodring maintains Alamar Biosciences (NASDAQ:ALMR) with a Overweight and raises the price target from $32 to $35.